Growth hormone response to thyrotropin-releasing hormone in acromegalic patients: reproducibility and dose-response study.

Growth hormone response to acute growth hormone releasing hormone administration in uraemic patients on haemodialysis.

Increased growth hormone response to growth hormone releasing hormone induced by erythropoietin in uraemic patients.

Induction of growth hormone and prolactin secretion by luteinizing hormone-releasing hormone and its blockade by bromoergocriptine in acromegalic patients.

Failure of naloxone to alter growth hormone and prolactin levels in acromegalic and in hyperprolactinaemic patients.

Longitudinal changes in growth hormone response to growth hormone-releasing hormone in neonatal rhesus monkeys.

Effect of galanin on the growth hormone response to growth hormone-releasing hormone in acromegaly.

The growth hormone response to growth hormone releasing hormone in patients previously treated with bilateral adrenalectomy alone for Cushing's disease.

Sex differences in growth hormone response to growth hormone-releasing hormone.

Carbidopa inhibits the growth hormone- and prolactin-suppressive effect of L-dopa in acromegalic patients.

Effects of exogenous growth hormone pretreatment on the pituitary growth hormone response to growth hormone-releasing hormone alone or in combination with pyridostigmine in type I diabetic patients.

Growth hormone and prolactin release in acromegalic patients following metergoline administration.

Effect of bromoergocriptine on TRH-induced growth hormone and prolactin release in acromegalic patients.

The dynamics of growth hormone and prolactin secretion in acromegalic patients with "mixed" pituitary tumours.

Pyridostigmine partially reverses dexamethasone-induced inhibition of the growth hormone response to growth hormone-releasing hormone.

Sexual dimorphic porcine pituitary response to growth hormone-releasing hormone.

Decreased growth hormone response to growth hormone-releasing hormone in Turner's syndrome: relation to body weight and adiposity.

Growth-hormone response to haemodialysis in children.

Response to growth hormone-releasing hormone in adult renal failure patients on hemodialysis.

Enhanced growth hormone responses to growth hormone releasing hormone in male type I diabetic patients.

Increased growth hormone responses to growth hormone releasing hormone and thyrotropin releasing hormone in patients with metastatic testicular cancer.

Genetically lean and fat sheep differ in their growth hormone response to growth hormone-releasing factor.

Dose dependence of growth response to human growth hormone in growth hormone deficiency.

Five-year response to growth hormone in children with Noonan syndrome and growth hormone deficiency.

Growth hormone (GH) response to clonidine and growth hormone releasing factor (GRF) in normal controls.

Suggest Documents

Growth hormone response to acute growth hormone releasing hormone administration in uraemic patients on haemodialysis.

Increased growth hormone response to growth hormone releasing hormone induced by erythropoietin in uraemic patients.

Induction of growth hormone and prolactin secretion by luteinizing hormone-releasing hormone and its blockade by bromoergocriptine in acromegalic patients.

Failure of naloxone to alter growth hormone and prolactin levels in acromegalic and in hyperprolactinaemic patients.

Longitudinal changes in growth hormone response to growth hormone-releasing hormone in neonatal rhesus monkeys.

Effect of galanin on the growth hormone response to growth hormone-releasing hormone in acromegaly.

The growth hormone response to growth hormone releasing hormone in patients previously treated with bilateral adrenalectomy alone for Cushing's disease.

Sex differences in growth hormone response to growth hormone-releasing hormone.

Carbidopa inhibits the growth hormone- and prolactin-suppressive effect of L-dopa in acromegalic patients.

Effects of exogenous growth hormone pretreatment on the pituitary growth hormone response to growth hormone-releasing hormone alone or in combination with pyridostigmine in type I diabetic patients.

Growth hormone and prolactin release in acromegalic patients following metergoline administration.

Effect of bromoergocriptine on TRH-induced growth hormone and prolactin release in acromegalic patients.

The dynamics of growth hormone and prolactin secretion in acromegalic patients with "mixed" pituitary tumours.

Pyridostigmine partially reverses dexamethasone-induced inhibition of the growth hormone response to growth hormone-releasing hormone.

Sexual dimorphic porcine pituitary response to growth hormone-releasing hormone.

Decreased growth hormone response to growth hormone-releasing hormone in Turner's syndrome: relation to body weight and adiposity.

Growth-hormone response to haemodialysis in children.

Response to growth hormone-releasing hormone in adult renal failure patients on hemodialysis.

Enhanced growth hormone responses to growth hormone releasing hormone in male type I diabetic patients.

Increased growth hormone responses to growth hormone releasing hormone and thyrotropin releasing hormone in patients with metastatic testicular cancer.

Genetically lean and fat sheep differ in their growth hormone response to growth hormone-releasing factor.

Dose dependence of growth response to human growth hormone in growth hormone deficiency.

Five-year response to growth hormone in children with Noonan syndrome and growth hormone deficiency.

Growth hormone (GH) response to clonidine and growth hormone releasing factor (GRF) in normal controls.

Growth hormone response to thyrotropin-releasing hormone in acromegalic patients: reproducibility and dose-response study.

Recommend Documents

Follow Us